GENE ONLINE|News &
The Maturation of Blood-Based Diagnostics to Nip Cancers in the Bud: An Interview with Dr. Jimmy Lin
The war against cancer is far from over, but modern medicine has made significant progress in winning some critical battles. Thanks to the rise of new modalities, cancer diagnosis and treatment have seen practice-changing advances. Liquid biopsy, the latest entrant to precision oncology, enables the screening of cancer prevalence and detects multiple cancers with a single blood test. However, there is merit in choosing to tackle one cancer at a time using a multi-pronged approach, says Dr. Jimmy Lin, Chief Scientific Officer of Freenome.
It's free! Log in now to read
Current Trends of iPSC Manufacturing and Clinical Applications – An Interview with Professor Xianmin Zeng
Cell & Gene Therapy Summit 2023
Boston Chinese Investment Club 2023 Biotech Pitch Competition
3rd INTERNATIONAL CONFERENCE ON NUTRITION AND HEALTHCARE